WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2018

Feb 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2018-02-26

Reporting Person: Abraham Silji (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-26	Common Stock	A	4638.00	$0.00	Acquired	4638.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-26	Stock Options (Right to buy)	$86.24	A	10520.00	Acquired	2028-02-26	Common Stock (10520.00)	Direct

Footnotes

F1: This award vests over 3 years starting on the 1st anniversary date of the award.

F2: This award vests in 4 equal annual installments beginning on 2/26/2019.